Description

Wegovy® (Semaglutide Injection) 0.25 mg / 0.5 mL. The 0.25 mg dose is the starter dose of Wegovy, designed to help the body gradually adjust to semaglutide therapy while minimizing gastrointestinal side effects before dose escalation.

Why Order Wegovy 0.25 mg from Weight Loss RX?

• FDA-Approved Weight Loss Medication
• Starter Dose for New Patients
• Once-Weekly Injection
• Appetite & Portion Control Support
• Refrigerated Next Day Air Shipping
• Signature Required for Secure Delivery

Product Overview

Medication Name: Wegovy®
Generic Name: Semaglutide
Manufacturer: Novo Nordisk
Drug Class: GLP-1 Receptor Agonist
Prescription Required: Yes

Strength & Package

• 0.25 mg / 0.5 mL per pen
• 4 prefilled single-use pens per box (4-week supply)

Form

• Disposable, prefilled subcutaneous injection pens
• Designed for simple, at-home self-administration

FDA-Approved Indication

Wegovy is approved for chronic weight management in adults who:

• Have a BMI ≥30 (obesity), or
• Have a BMI ≥27 (overweight) with at least one weight-related condition
  (e.g., hypertension, type 2 diabetes, dyslipidemia)

Wegovy is intended for long-term weight management and is not a cosmetic weight loss medication.

How Wegovy Works

Wegovy contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist that helps regulate appetite and energy balance by:

• Reducing hunger signals
• Increasing feelings of fullness
• Slowing gastric emptying
• Decreasing overall calorie intake

In large clinical trials, patients using Wegovy lost an average of ~15% of body weight over 68 weeks, with early weight reduction beginning within the first month.

Benefits of Wegovy 0.25 mg (Starter Dose)

• Helps the body adjust to GLP-1 therapy
• Reduces appetite and food cravings
• Supports early, gradual weight loss
• Once-weekly dosing convenience
• Clinically tested and FDA-approved

Note: The 0.25 mg dose is not intended as a maintenance dose. Most patients transition to higher doses under provider supervision.

Administration & Storage

How to Use Wegovy

• Inject once weekly, on the same day each week
• Injection sites: abdomen, thigh, or upper arm
• Rotate injection sites weekly to avoid irritation

Storage Instructions

• Refrigeration required
• Store at 36°F–46°F (2°C–8°C)
• Do not freeze
• Protect from light

Shipping Notice:

• Refrigerated Item
• Ships Next Day Air
• Signature Required — recipient must be available

Possible Side Effects

Common Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal discomfort
• Decreased appetite

Side effects are most common during early therapy and dose escalation and often improve with continued use.

Serious Side Effects (Seek Medical Attention)

• Severe abdominal pain (possible pancreatitis)
• Gallbladder disease
• Kidney problems
• Severe allergic reactions

Important Safety Information

• Thyroid C-Cell Tumors: Do not use if you or a family member has had medullary thyroid carcinoma (MTC) or MEN 2
• Pregnancy & Breastfeeding: Not recommended
• Pancreatitis: Discontinue if suspected
• Drug Interactions: Inform your provider of all medications

Use only as prescribed by a licensed healthcare provider.